Skip to content
Clinical Trials – home

Secondary progressive multiple sclerosis

  • 8 clinical trials
  • 2 recruiting
  • 25 countries
Quick filters

8 Clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Novartis Pharma AG

Relapsing multiple sclerosis+2

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Cladribine
  • Sponsor:Instytut Psychiatrii I Neurologii
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Region Hovedstaden
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.